HC Wainwright & Co. Reiterates Buy on Rockwell Medical, Maintains $7 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Rockwell Medical (NASDAQ:RMTI) with a Buy and maintains $7 price target.
Rockwell Medical Q3 EPS $(0.40) Beats $(0.48) Estimate, Sales $18.69M Miss $19.37M Estimate
Rockwell Medical (NASDAQ:RMTI) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.48) by 16.67 percent. This is a 55.06 percent increase over losses of $(0.89) per share from
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Analyst Hikes Price Target, Expects Rockwell Medical To Take Steps To Improve Debt Position
HC Wainwright has increased the price target on Rockwell Medical Inc (NASDAQ:RMTI) from $3 to $8, with a Buy rating, reflecting a 1-for-11…
Rockwell Medical Q2 EPS $(0.56) Up From $(0.99) YoY, Sales $18.70M Beat $16.80M Estimate
Rockwell Medical (NASDAQ:RMTI) reported quarterly losses of $(0.56) per share. This is a 43.43 percent increase over losses of $(0.99) per share from the same period last year. The company reported quarterly sales of
Earnings Scheduled For August 15, 2022
Companies Reporting Before The Bell
• Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.
